Related Experiment Videos
Specific targeting of human papillomavirus type 16 E7 oncogene with triple-helix forming purine
Abstract:
Molecular mechanical calculations (computer modelling), optical DNA melting experiments and co-migration assay were used to assess stable helix formation at homopurine--homopyrimidine-rich target sites present in the human papillomavirus type 16 E7 oncogene (positions 656-673 on the genome map). The target sequence, either present in the E7 oncogene obtained by PCR technique or prepared from oligodeoxyribonucleotides (ODNs), can be specifically recognised by different 17-merpurine ODNs designed to form antiparallel or parallel triple helices. These in vitro experiments realised with rather long purine ODNs having a high degree of specificity open the way for in vivo tests focused on E7 oncogene targeting and suppression.
Insights
Researchers explored stable helix formation in the human papillomavirus type 16 E7 oncogene using molecular modeling and DNA melting experiments. Oligodeoxynucleotides (ODNs) targeting the E7 oncogene show promise for future in vivo gene suppression applications.
Area of Science:
- Molecular Biology
- Bioinformatics
- Genetics
Background:
- The human papillomavirus type 16 (HPV16) E7 oncogene is a key factor in cervical cancer development.
- Targeting oncogenes offers a potential strategy for cancer therapy.
- Understanding DNA structural dynamics is crucial for developing novel therapeutic approaches.
Purpose of the Study:
- To investigate stable triple helix formation at specific sites within the HPV16 E7 oncogene.
- To evaluate the potential of oligodeoxynucleotides (ODNs) for targeting and suppressing the E7 oncogene.
Main Methods:
- Molecular mechanical calculations (computer modeling) were employed to simulate DNA interactions.
- Optical DNA melting experiments were conducted to assess helix stability.
- Co-migration assays were utilized to confirm specific ODN binding.
- Polymerase chain reaction (PCR) was used to obtain the target E7 oncogene sequence.
Main Results:
- Stable helix formation was confirmed at homopurine-homopyrimidine-rich target sites in the HPV16 E7 oncogene (positions 656-673).
- Specific recognition and binding of 17-mer purine ODNs were demonstrated, forming both parallel and antiparallel triple helices.
- The designed ODNs exhibited a high degree of specificity for the target sequence.
Conclusions:
- In vitro studies demonstrate the feasibility of using specific ODNs to target the HPV16 E7 oncogene.
- These findings pave the way for in vivo investigations into E7 oncogene targeting and suppression strategies.
- The development of highly specific ODNs offers a promising avenue for potential therapeutic interventions against HPV16-associated cancers.